Asztma: vizsgálatok itt: Bosznia-Hercegovina
1 trial · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleTherapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
- Where
- Banja Luka, Doboj, Sarajevo, Siroki Brijeg, Tešanj, Tuzla
- Életkor
- 18 év to 75 év
- People
- 780 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00